Analysts expect UnitedHealth Group Inc (NYSE:UNH) to report sales of $54.85 billion for the current quarter, according to Zacks Investment Research. Six analysts have provided estimates for UnitedHealth Group’s earnings. The lowest sales estimate is $54.15 billion and the highest is $55.38 billion. UnitedHealth Group reported sales of $48.72 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 12.6%. The business is expected to announce its next earnings results on Tuesday, April 17th.
According to Zacks, analysts expect that UnitedHealth Group will report full year sales of $54.85 billion for the current year, with estimates ranging from $223.50 billion to $225.58 billion. For the next fiscal year, analysts forecast that the firm will post sales of $242.64 billion per share, with estimates ranging from $240.11 billion to $245.44 billion. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. During the same period last year, the company posted $2.11 earnings per share. The firm’s quarterly revenue was up 9.5% compared to the same quarter last year.
A number of brokerages have recently weighed in on UNH. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a research note on Saturday, January 20th. Argus raised their target price on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a research note on Thursday, January 18th. Credit Suisse Group raised their target price on UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Oppenheimer raised their target price on UnitedHealth Group from $260.00 to $240.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Finally, Cantor Fitzgerald lifted their price objective on UnitedHealth Group to $280.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $243.22.
In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Michele J. Hooper sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total value of $2,377,600.00. Following the transaction, the director now owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 53,396 shares of company stock worth $12,262,067. Company insiders own 0.89% of the company’s stock.
A number of institutional investors and hedge funds have recently modified their holdings of UNH. Exane Derivatives lifted its holdings in shares of UnitedHealth Group by 15,333.3% during the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after purchasing an additional 460 shares in the last quarter. Aevitas Wealth Management Inc. bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $102,000. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $110,000. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares in the last quarter. Hedge funds and other institutional investors own 85.65% of the company’s stock.
Shares of UnitedHealth Group (NYSE UNH) traded up $3.07 during trading hours on Wednesday, hitting $230.16. The stock had a trading volume of 2,349,926 shares, compared to its average volume of 4,430,000. UnitedHealth Group has a 52 week low of $161.74 and a 52 week high of $250.79. The firm has a market capitalization of $222,720.00, a price-to-earnings ratio of 24.23, a PEG ratio of 1.32 and a beta of 0.70. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.73 and a current ratio of 0.73.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be issued a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.30%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 31.58%.
ILLEGAL ACTIVITY NOTICE: This report was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/24/54-85-billion-in-sales-expected-for-unitedhealth-group-inc-unh-this-quarter.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Get a free copy of the Zacks research report on UnitedHealth Group (UNH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.